Shanghai Medicilon Inc
SSE:688202
Shanghai Medicilon Inc
Cash from Operating Activities
Shanghai Medicilon Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Medicilon Inc
SSE:688202
|
Cash from Operating Activities
-¥21.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Operating Activities
¥13.4B
|
CAGR 3-Years
50%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Operating Activities
¥2.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Operating Activities
¥6.8B
|
CAGR 3-Years
54%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
31%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash from Operating Activities
¥1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Medicilon Inc's Cash from Operating Activities?
Cash from Operating Activities
-21.3m
CNY
Based on the financial report for Dec 31, 2022, Shanghai Medicilon Inc's Cash from Operating Activities amounts to -21.3m CNY.